Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

PERK deficiency amplifies molecular, structural, and network vulnerability to repetitive mild traumatic brain injury.
Examining the Impact of Perceived and Objective Cognitive Function on Social Participation in Individuals with Multiple Sclerosis.
Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview.
Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease.
Roles of Metformin and Pioglitazone in Regulating A1-like Astrocyte Activation in EAE Mice.
Infliximab-associated multifocal central nervous system demyelination mimicking multiple sclerosis in a patient with Crohn's disease: a case report.
Uncovering Spatiotemporal and Functional Dynamics of Long Non-coding RNAs During Alzheimer's Progression in the Human Brain at Single-Cell Resolution.
Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study.
Dual role of Ninjurin-1 in myeloid cell adhesion and inflammation in relapse-remitting EAE.
AI-Powered Gradient Echo Plural Contrast Imaging (AI-GEPCI)-A Comprehensive Neurological Protocol From a Single MRI Scan.
Quantitative Assessment of Peripheral Nerve Echogenicity in Children and Adolescents Aged 2-17 Years: A Retrospective Cross-Sectional Ultrasound Study.
Beyond PAD Inhibition: Emerging Avenues and Natural Products for Targeting Citrullination in Immune Diseases.
The evolution of criteria for assessing disease activity and progression in multiple sclerosis (or the "saga of acronyms").
Chronic Inflammatory Demyelinating Polyneuropathy in a Patient With Autoimmune Autonomic Ganglionopathy: A Case Report.
Correction to: Identification of diagnostic biomarkers for relapsing-remitting multiple sclerosis in plasma by mass spectrometry-based proteomics.
Evaluation of the DTI-ALPS index in neuromyelitis optica spectrum disorder: a cross-sectional study of its correlation with disease duration and disability.
Percutaneous spinal stimulation to enhance gait and alleviate functional impairments in multiple sclerosis: A pilot study.
Immune-Mediated Demyelinating Polyradiculoneuropathies Linked to Systemic Lupus Erythematosus (SLE): A Systematic Review of Clinical Features, Diagnostic and Treatment Modalities.
Handcrafted Versus Deep Feature Extraction Methods for MRI-Based Multiple Sclerosis Diagnosis.
Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration.
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.
The Impact of Task-Oriented Training on Health Outcomes in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Validation of a new diagnostic ELISA to detect anti-JCV antibodies in serum of patients with multiple sclerosis considering or receiving treatment with natalizumab.
Efficacy of transcranial direct current stimulation on motor and cognitive functions in patients with multiple sclerosis: a systematic review and meta-analysis.
The evolution of CAR therapies across oncology and autoimmunity: mechanistic insights and therapeutic innovations.

Pages